RecruitingNCT07750288
Rare condition
Pediatric acute respiratory distress syndrome
10
studies recruiting now
as of 7 Sept 2026
71
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
6 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07193771
Altitude and Outcomes in Pediatric ARDS: A Multicenter Study
RecruitingNot applicableNCT04068012
Clinical Decision Support Tool in PARDS Pilot Study
RecruitingNCT07414056
Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation
RecruitingNCT06750536
Evaluating the Safety and Performance of the MiniLung Petite Kit in Neonatal and Pediatric Patients With Acute Respiratory and Cardiac Failure
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 10 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Pediatric acute respiratory distress syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Pediatric acute respiratory distress syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (ABCA3, SFTPB, SFTPC).
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).